Match Document Document Title
10188747 Methods and compositions for the treatment of cancer  
The technology described herein is directed to agonists of, e.g. Esr2, Dlx5, and/or Egr3, for the inhibition of cancer cells (e.g. squamous carcinoma cancer cells) and the treatment of cancer.
10188743 Cytisine-linked isoflavonoid antineoplastic agents for the treatment of cancer  
Cytisine-linked isoflavonoids, or pharmaceutically acceptable salts thereof or pharmaceutically acceptable compositions thereof, are useful for the treatment of conditions in which cells have a...
10188731 Methods for killing cancer cells and cellular imaging using magneto-electric nano-particles and external magnetic field  
This invention provides methods for achieving high-specificity killing of targeted cells using Magneto-Electric Nano-Particles (MENPs). Embodiments comprise injecting into a patients body...
10188728 Compositions and methods for treatment of cancer  
Provided are compositions, methods and kits for treating cancer comprising targeted liposomes comprising a chemotherapy agent and a sensitizer for the chemotherapy agent, and non-targeted...
10188713 Methods and materials for treating cancer  
This document provides methods and materials for treating cancer. For example, methods and materials for identifying antigens and combinations of antigens that can be used to treat cancer as well...
10188712 Tumor antigens for determining cancer therapy  
The present invention relates to the treatment of cancer, in particular breast cancer, particularly triple-negative breast cancer. More particularly, the invention concerns methods and means for...
10188704 Enhanced melanoma cancer prevention by novel melanotropins  
A gamma-melanocyte stimulating hormone (γ-MSH) derivative having improved stability, selectivity and bioavailabilty. The γ-MSH derivative is selective for the melanocortin-1 receptor (MC1 R) and...
10188699 CAPCNA peptide therapeutics for cancer  
Administration of compositions comprising cell-permeable cancer-specific proliferating cell nuclear antigen derived peptides and their variants reduces the proliferation of cancer cells and also...
10188689 Method and composition for treating breast cancer  
The invention disclosed herein relates to the use of an extract of Dodonaea viscosa in breast cancer therapy, either alone or in combination with other breast cancer therapies.
10188668 Cancer drug and uses  
A pharmaceutical composition comprising a cancer therapeutic that is capable of inhibiting and/or reducing the ability of a cancer cell to take up and utilize glucose or other energy source, a...
10188654 Uses of pyrimido-pyridazinones to treat cancer  
Disclosed are methods of treating cancer, which include administering a therapeutically effective amount of a compound of Formula (I), or a pharmaceutically acceptable salt or ester thereof, to a...
10188622 Use of a composition comprising fish oil and juice for the treatment and/or post treatment of cancer  
Disclosed is a composition including a fish oil and a juice in an oil-in-water emulsion for use in treatment and post-treatment of cancer.
10188618 Treatment of cancer with specific RXR agonists  
A method of treating cancer is disclosed comprising administering to a patient in need of such treatment a RXR agonist at a level below the RAR activating threshold and at or above the RXR...
10186332 Determination device, computer readable medium, and marker for obtaining information on lung cancer  
A determination device for enabling a computer to carry out a process including the steps of: obtaining an analysis result on methylation status of a CpG site located in a promoter region of at...
10184943 Multiple biomarker set for breast cancer diagnosis, method of detecting the same, and diagnosis kit for breast cancer using antibody against the same  
The present invention relates to a biomarker set for diagnosing breast cancer comprising two or more protein markers of: apolipoprotein C1, apolipoprotein (a), neural cell adhesion molecule...
10184942 Natriuretic peptide receptor as a biomarker for diagnosis and prognosis of cancer  
The invention pertains to biomarkers for clinical detection of malignancies, especially for early detection of cancers. More specifically, this invention pertains to the role of Natriuretic...
10184894 Cancer diagnostic device, diagnostic system, and diagnostic device  
A target is irradiated in a time-shared manner with a visible-light-range illumination light source and an infrared laser beam for Raman scattering, and a target image is formed with an...
10184113 Ex vivo human multiple myeloma cancer niche and its use as a model for personalized treatment of multiple myeloma  
The described invention provides an ex vivo dynamic multiple myeloma (MM) cancer niche contained in a microfluidic device. The dynamic MM cancer niche includes (a) a three-dimensional tissue...
10184007 Methods of treating a kit-associated cancer by administering anti-kit antibodies  
Provided herein, in one aspect, are antibodies that immunospecifically bind to a human KIT antigen comprising the fourth and/or fifth extracellular Ig-like domains (that is, D4 and/or D5 domains),...
10184006 Biomarkers for predicting outcomes of cancer therapy with ErbB3 inhibitors  
Methods for predicting a therapeutic response in a patient (e.g., a cancer patient) to ErbB3 inhibitors, and methods of treating a cancer patient with targeted therapies.
10183993 Compositions and methods for treating cancer with anti-mesothelin immunotherapy  
Chimeric antigen receptors containing mesothelin antigen binding domains are disclosed. Nucleic acids, recombinant expression vectors, host cells, antigen binding fragments, and pharmaceutical...
10183925 Substituted naphtho[2,3-b]furans as water-soluble prodrugs for preventing and/or treating cancer  
The present invention provides compounds represented by formula (1A), or pharmaceutically acceptable salts. Compounds represented by formula (1A), or pharmaceutically acceptable salts thereof,...
10183912 HDMX inhibitors and their use for cancer treatment  
The present invention provides for novel acridine-like class of compounds that have demonstrated efficiency in treating cancer. The compounds of the present invention have demonstrated efficacy in...
10183175 Cancer detection and treatment apparatus  
A catheter treatment apparatus comprises an elongate tubular member and an expandable support. The expandable support comprises a radioactive substance to treat cancerous tissue and is configured...
10183062 Treatment for cancer  
The present invention provides a method of treatment for cancer in a subject comprising the administration of a prodrug, wherein the subject is colonised with an obligate anaerobic microorganism...
10183058 Method of preventing or reducing the progression of prostate cancer  
The embodiments include methods of preventing or reducing the progression of prostate cancer in mammals susceptible to developing prostate cancer, and to methods of reducing the incidence of...
10183035 Etoposide and prodrugs thereof for use in targeting cancer stem cells  
The present invention pertains to the use of podophyllotoxin derivatives, such as CAP7.1, in methods for inhibition of and/or prevention of the growth and/or survival of cancer stem cells. The...
10183019 Treatment of cancer with dihydropyrazino-pyrazines  
Provided herein are methods for treating or preventing glioblastoma multiforme (GBM) characterized by O6-methylguanine-DNA methyltransferase (MGMT) expression and/or promoter methylation status,...
10182997 Liposomal curcumin for treatment of cancer  
The present invention provides a compositions and methods for the treatment of cancer, including pancreatic cancer, breast cancer and melanoma, in a human patient. The methods and compositions of...
10181009 Methods and systems for predicting cancer outcome  
The invention provides a molecular marker set that can be used for prognosis of colorectal cancer in a colorectal cancer patient. The invention also provides methods and computer systems for...
10181008 Gene expression profile algorithm for calculating a recurrence score for a patient with kidney cancer  
The present invention provides algorithm-based molecular assays that involve measurement of expression levels of genes from a biological sample obtained from a kidney cancer patient. The present...
10179936 Gene expression profile algorithm and test for likelihood of recurrence of colorectal cancer and response to chemotherapy  
Algorithm-based molecular assays that involve measurement of expression levels of prognostic and/or predictive genes, or co-expressed genes thereof, from a biological sample obtained from a cancer...
10179935 Markers for detection of gastric cancer  
Early detection of tumors is a major determinant of survival of patients suffering from tumors, including gastric tumors. Members of the GTM gene family can be over-expressed in gastric tumor...
10179914 CDC25A inhibitor for the treatment of drug resistant cancer or for the prevention of tumor relapse  
The present invention concerns a CDC25A phosphatase inhibitor for use in the treatment of a drug resistant cancer and/or in prevention of tumor relapse in a patient suffering or having suffered...
10179790 MTH1 inhibitors for treatment of cancer  
A compound of formula I, (I) or a pharmaceutically-acceptable salt thereof. The compound is useful in the treatment of cancer.
10179789 Methylenedioxybenzo [I] phenanthridine derivatives used to treat cancer  
The invention provides compounds of formula I: wherein A, B, X, and Y have any of the values defined in the specification, as well as pharmaceutical compositions comprising such compounds,...
10179164 Method for inducing an immune response for treatment of cancer and autoimmune diseases or conditions  
The invention is related to peptide constructs, i.e., polypeptides obtained by linking together two or more peptides based on or derived from different molecules, which are useful in the treatment...
10179156 Medicament containing taraxacum plant root extract for treatment or prevention of cancer, and method for preparing same  
The present invention relates to an improved method for preparing a medicament comprising a Taraxacum plant root extract for the treatment or prevention of a cancer. In one aspect, the method...
10179154 Chimeric VSV virus compositions and methods of use thereof for treatment of cancer  
Methods of treating cancer including administering to a subject with cancer a pharmaceutical composition including an effective amount of a chimeric VSV virus are disclosed. The chimeric viruses...
10179133 Pyrrolopyrimidine compounds for the treatment of cancer  
Compounds of Formula I: wherein: one of X and X′ is N and the other of X and X′ is C, are described, along with compositions containing the same and methods of use thereof in the treatment of cancer.
10176577 System for determining a cancer diagnosis score derived from stained nuclei  
Certain aspects of an apparatus and method for automatic ER/PR scoring of tissue samples may include for determining a cancer diagnosis score comprising identifying a positive stained nucleus in a...
10175243 Use of CD36 to identify cancer subjects for treatment  
Provided herein are methods for identifying a subject with cancer for treatment with a Psap peptides. The subject is identified based on a level of CD36. Also provided herein are compositions and...
10175241 ASC as a marker for lung cancer  
The present invention relates to the assessment of lung cancer. It discloses the use of protein ASC in the assessment of lung cancer. It also relates to a method for assessing lung cancer in vitro...
10175240 Method for determining breast cancer treatment  
The present invention provides a method for determining a treatment procedure for breast cancer, a method of predicting a likelihood of success in treating breast cancer, and a method for...
10174384 Use of the ZMIZ1 marker in directing treatment and predicting survival in cancer  
The present invention relates to the field of cancer. More specifically, the present invention provides methods and compositions for treating cancer and predicting patient survival. In one...
10174382 Breast cancer prognostication and screening kits and methods of using same  
A genetic biomarker panel is provided for prognosing late onset ER+ breast cancer relapse, in a breast cancer survivor patient. Kits are also provided for measuring levels or the presence of an...
10174322 Short interfering RNA for treating cancer  
Disclosed herein is novel double-stranded short interfering ribonucleic acid (siRNA) capable of suppressing the translation of Aurora-A mRNA. Also disclosed are use of the novel siRNA as disclosed...
10174314 MiRNA for treating head and neck cancer  
The invention relates to the diagnostic and therapeutic uses of a miRNA-323, miRNA-342, miRNA-326, miRNA-371, miRNA-3157 and/or miRNA-345 molecule, an equivalent or a source thereof in a disease...
10174117 Anti-HER2 single domain antibodies, polypeptides comprising thereof and their use for treating cancer  
The present invention relates to anti-HER2 single domain antibodies, polypeptides comprising thereof and their use for treating cancer.
10174104 Monoclonal antibodies against claudin-18 for treatment of cancer  
The present invention provides antibodies useful as therapeutics for treating and/or preventing diseases associated with cells expressing CLD18, including tumor-related diseases such as gastric...